chloroquine has been researched along with Genetic Skin Diseases in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chloroquine was started at a dose of 4 mg/kg daily for 10 days, then 250 mg daily for next the 10 weeks, resulting in complete clearance of all the lesions, which was sustained for over 2 years of follow-up." | 5.48 | Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine. ( Bartolić, L; Bradamante, M; Ljubojević Hadžavdić, S, 2018) |
| "Chloroquine was started at a dose of 4 mg/kg daily for 10 days, then 250 mg daily for next the 10 weeks, resulting in complete clearance of all the lesions, which was sustained for over 2 years of follow-up." | 1.48 | Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine. ( Bartolić, L; Bradamante, M; Ljubojević Hadžavdić, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ljubojević Hadžavdić, S | 1 |
| Bartolić, L | 1 |
| Bradamante, M | 1 |
1 other study available for chloroquine and Genetic Skin Diseases
| Article | Year |
|---|---|
Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine.
Topics: Antimalarials; Chloroquine; Eosinophilia; Erythema; Humans; Male; Middle Aged; Skin Diseases, Geneti | 2018 |